{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:08:04Z","timestamp":1781651284731,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10067-015-3082-z","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T02:38:51Z","timestamp":1443494331000},"page":"1181-1188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases"],"prefix":"10.1007","volume":"35","author":[{"given":"Naoto","family":"Umeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshimi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kurashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ogishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Sakyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"3082_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/s10165-011-0486-8","volume":"22","author":"P Suwannalai","year":"2012","unstructured":"Suwannalai P, Trouw LA, Toes RE, Huizinga TW (2012) Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol 22:15\u201320","journal-title":"Mod Rheumatol"},{"key":"3082_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","volume":"34","author":"A Suzuki","year":"2003","unstructured":"Suzuki A, Yamada R, Chang X et al (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395\u2013402","journal-title":"Nat Genet"},{"key":"3082_CR3","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/art.21309","volume":"52","author":"K Ikari","year":"2005","unstructured":"Ikari K, Kuwahara M, Nakamura T et al (2005) Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 52:3054\u20137","journal-title":"Arthritis Rheum"},{"key":"3082_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/art.21536","volume":"54","author":"CP Kang","year":"2006","unstructured":"Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC (2006) A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 54:90\u20136","journal-title":"Arthritis Rheum"},{"key":"3082_CR5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/s10165-012-0639-4","volume":"23","author":"S Hou","year":"2013","unstructured":"Hou S, Gao GP, Zhang XJ et al (2013) PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mod Rheumatol 23:50\u201360","journal-title":"Mod Rheumatol"},{"key":"3082_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","volume":"63","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Radstake TR, van der Heijden A et al (2004) Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 63:373\u201381","journal-title":"Ann Rheum Dis"},{"key":"3082_CR7","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1002\/art.22983","volume":"56","author":"C Foulquier","year":"2007","unstructured":"Foulquier C, Sebbag M, Clavel C et al (2007) Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 56:3541\u201353","journal-title":"Arthritis Rheum"},{"key":"3082_CR8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/s10165-012-0748-0","volume":"23","author":"A Ishigami","year":"2013","unstructured":"Ishigami A, Uchida Y, Miyazaki T et al (2013) Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis. Mod Rheumatol 23:794\u2013803","journal-title":"Mod Rheumatol"},{"key":"3082_CR9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2007.080267","volume":"67","author":"EH Halvorsen","year":"2008","unstructured":"Halvorsen EH, Pollmann S, Gilboe IM et al (2008) Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis 67:414\u20137","journal-title":"Ann Rheum Dis"},{"key":"3082_CR10","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.27570","volume":"62","author":"JR Kolfenbach","year":"2010","unstructured":"Kolfenbach JR, Deane KD, Derber LA et al (2010) Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheum 62:2633\u20139","journal-title":"Arthritis Rheum"},{"key":"3082_CR11","doi-asserted-by":"crossref","unstructured":"Darrah E, Giles JT, Ols ML, Bull HG, Andrade F, Rosen A. (2013) Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Sci Transl Med 5:186R65.","DOI":"10.1126\/scitranslmed.3005370"},{"key":"3082_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","volume":"233","author":"N Wegner","year":"2010","unstructured":"Wegner N, Lundberg K, Kinloch A et al (2010) Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 233:34\u201354","journal-title":"Immunol Rev"},{"key":"3082_CR13","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar2011","volume":"8","author":"B Vander Cruyssen","year":"2006","unstructured":"Vander Cruyssen B, Cantaert T, Nogueira L et al (2006) Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther 8:R122","journal-title":"Arthritis Res Ther"},{"key":"3082_CR14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","volume":"68","author":"O Snir","year":"2009","unstructured":"Snir O, Widhe M, von Spee C et al (2009) Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 68:736\u201343","journal-title":"Ann Rheum Dis"},{"key":"3082_CR15","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","volume":"58","author":"K Lundberg","year":"2008","unstructured":"Lundberg K, Kinloch A, Fisher BA et al (2008) Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 58:3009\u201319","journal-title":"Arthritis Rheum"},{"key":"3082_CR16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.12033","volume":"172","author":"N Umeda","year":"2013","unstructured":"Umeda N, Matsumoto I, Ito I et al (2013) Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity. Clin Exp Immunol 172:44\u201353","journal-title":"Clin Exp Immunol"},{"key":"3082_CR17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"3082_CR18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20138","journal-title":"Ann Rheum Dis"},{"key":"3082_CR19","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"3082_CR20","first-page":"969","volume":"35","author":"J Zhao","year":"2008","unstructured":"Zhao J, Zhao Y, He J, Jia R, Li Z (2008) Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol 35:969\u201374","journal-title":"J Rheumatol"},{"key":"3082_CR21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3899\/jrheum.130293","volume":"40","author":"ED Ferucci","year":"2013","unstructured":"Ferucci ED, Darrah E, Smolik I et al (2013) Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations. J Rheumatol 40:1523\u20138","journal-title":"J Rheumatol"},{"key":"3082_CR22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/art.27439","volume":"62","author":"F Andrade","year":"2010","unstructured":"Andrade F, Darrah E, Gucek M, Cole RN, Rosen A, Zhu X (2010) Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum 62:1630\u201340","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-3082-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3082-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:43Z","timestamp":1559120263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-3082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3082"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-3082-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}